ASCO 2015: Elective Neck Dissection Improved Survival in Early Node-Negative Oral Cancer
A phase 3, randomised controlled trial showed that elective neck dissection improved overall survival by 12.5% and reduced risk of death by 36% when compared with a wait-and-watch approach for therape...
Author: EMJ
Added: 06/04/2015 (Source: Oncology Tube)
Source: Oncology Tube - June 4, 2015 Category: Cancer & Oncology Source Type: podcasts
Treatment Associated With Survival in Early-Stage Oral Cavity Cancer (JAMA Otolaryngology-Head & Neck Surgery)
Interview with Benjamin L. Judson, MD and Alexander L. Luryi, BS, authors of Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 14, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : Treatment Associated With Survival in Early-Stage Oral Cavity Cancer
Interview with Benjamin L. Judson, MD and Alexander L. Luryi, BS, authors of Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 14, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Treatment Associated With Survival in Early-Stage Oral Cavity Cancer (JAMA Otolaryngology-Head & Neck Surgery)
Interview with Benjamin L. Judson, MD and Alexander L. Luryi, BS, authors of Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - May 14, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
New drug shows improvement in survival of advanced thyroid cancer
In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free sur...
Author: mdanderson
Added: 02/11/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 11, 2015 Category: Cancer & Oncology Source Type: podcasts
Living With Thyroid Cancer: Oral Issues - Dry Mouth
Featuring Tracy Rode (thyroid cancer survivor), Richard Cardoso, DDS, MS (University of Texas MD Anderson Cancer Center), and Steven I. Sherman, MD (University of Texas MD Anderson Cancer Center).
Author: vitaloptions
Added: 02/10/2015 (Source: Oncology Tube)
Source: Oncology Tube - February 11, 2015 Category: Cancer & Oncology Source Type: podcasts
ASH 2014: Dr Ian Flinn discusses the treatment of haematological malignancies with idelalisib
At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Ian Flinn (Sarah Cannon Cancer Institute, Nashville, TN) discusses the selective oral inhibitor of phosphoinositide 3-kinase (PI3K) ...
Author: EMJ
Added: 01/27/2015 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2015 Category: Cancer & Oncology Source Type: podcasts
Why Not Use Oral S-1 in Colon Cancer?
Dr David Kerr reports that S-1, an oral fluoropyrimidine used as adjuvant therapy in stage III colon cancer, is noninferior to a 3-drug regimen, suggesting that S-1 is a strong option in this setting. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - November 3, 2014 Category: Gastroenterology Authors: Medscape Source Type: podcasts
Top Ten Oral Hygiene Tips for Patients with Oral Cancer
Patients with cancer undergoing chemotherapy and radiation may be at risk for Oral Mucositis, a condition characterized by redness, inflammation and ulcer like sores throughout the mouth and throat. O...
Author: DARABioSciences
Added: 09/15/2014 (Source: Oncology Tube)
Source: Oncology Tube - September 15, 2014 Category: Cancer & Oncology Source Type: podcasts
TWiV 298: MV-NIS de myelo
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler
The TWiV gang answer follow-up questions about the Ebola virus outbreak in West Africa, then discuss treatment of disseminated multiple myeloma with oncolytic measles virus.
Links for this episode
Use of unregistered interventions for Ebola virus disease (WHO)
Response to anthrax and H5N1 incidents (CDC)
Remission of disseminated cancer after treatment with oncolytic measles virus (Mayo Clin Proc)
New viruses for cancer therapy (Nat Rev Micro)
Cattaneo on TWiV
Image credit
Letters read&nb...
Source: This Week in Virology - MP3 Edition - August 17, 2014 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Dr. Beth Overmoyer -- ASCO 2014
Results from a clinical study evaluating an oral daily dose of the drug enobosarm shows promise for women with metastatic, androgen receptor positive, breast cancer. The research was reported at the ...
Author: feeds
Added: 06/02/2014 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2014 Category: Cancer & Oncology Source Type: podcasts
Oral Cancer: The Signs of Oral Cancer
A persistent ulcerative, lesion or mouth sore that has lasted for more than 3-4 weeks should be checked by a dentist to rule out the possibility of an oral cancer. Dentist, Dr. Mark Barry explains what to look for in abnormal patches or lumps in the mouth, advises when to see your dentist and the importance of dentists performing oral cancer exams. (Source: MUSC Dental Podcast)
Source: MUSC Dental Podcast - April 5, 2014 Category: Dentistry Authors: Medical University of South Carolina Source Type: podcasts
HPV Oral Cancer and Cervical Cancer: A Study
This study reviews HPV oral cancer and its potential link to cervical cancer, differences between mobile and static populations, behavioral differences between whites and African Americans and age specific lifestyle differences. (Source: MUSC Cancer Podcast)
Source: MUSC Cancer Podcast - April 5, 2014 Category: Cancer & Oncology Authors: Medical University of South Carolina Source Type: podcasts
Promising Oral Myeloma Therapies
Where do we stand with oral therapies in development to treat myeloma? Dr. Paul Richardson, an expert from the Dana-Farber Cancer Institute, provides an overview of oral proteasome inhibitor treatment...
Author: patientpower
Added: 03/24/2014 (Source: Oncology Tube)
Source: Oncology Tube - March 25, 2014 Category: Cancer & Oncology Source Type: podcasts
Cancer Patient Compliance: Whose Responsibility? - What Are the Challenges Of the Medical Community
Dr. Alexandru Eniu discusses the importance of dialogue and communication
between patients and Doctors to ensure optimal treatment. With the expansion
of oral treatments, compliance and adherence ha...
Author: vitaloptions
Added: 01/23/2014 (Source: Oncology Tube)
Source: Oncology Tube - January 23, 2014 Category: Cancer & Oncology Source Type: podcasts